A photo taken in August 2024 shows the packaging for Pfizer's updated COVID-19 vaccine, which is approved by Health Canada for use in fall vaccination campaigns for people aged 12 and older. (Steven Decroos/The Canadian Press/Associated Press)
Health Canada has approved Pfizer-BioNTech's updated COVID-19 vaccine, designed to protect against a new variant that has been spreading recently. The vaccine, known as Comirnaty, has been reformulated specifically to target the KP.2 subvariant of the Omicron strain.
Pfizer announced that this new version of the vaccine will soon be available at pharmacies and vaccination centers across Canada, expected to roll out in the fall. The company encourages everyone to check with their local provincial and territorial health authorities for details on how to get vaccinated.
In addition to Pfizer's update, Health Canada also gave the green light to another mRNA vaccine from Moderna called Spikevax, as well as Novavax's protein-based vaccine known as Nuvaxovid, just last week.
Previously, Pfizer’s vaccine was focused on an earlier Omicron variant known as XBB.1.5. With the emergence of new variants, these updates are essential to ensure effective protection for the public.
The National Advisory Committee on Immunization (NACI) is urging everyone, especially those at high risk, to get the updated vaccines starting this fall. High-risk groups include adults aged 65 and older, residents of long-term care facilities, individuals with underlying health conditions, and people from Indigenous and marginalized communities. Pregnant individuals and essential community workers are also encouraged to receive the updated vaccine.
NACI has stated that all other adults and children aged six months and older should also be eligible for these updated COVID-19 vaccinations this season.
According to the latest data from the Public Health Agency of Canada, COVID-19 activity is moderate across the nation, though certain areas such as Yukon, British Columbia, Manitoba, New Brunswick, and Newfoundland and Labrador have reported high viral activity levels as of September 8.
Doctors and epidemiologists highlight that monitoring wastewater can provide early signals about increasing respiratory virus activity in communities. This method of testing allows health authorities to respond more quickly to potential outbreaks.
Both the new Pfizer and Moderna vaccines have been approved for use in adults as well as children aged six months and older, offering broader protection to younger populations.
As the fall approaches, staying updated with vaccinations is vital to safeguarding public health. With the changing landscape of COVID-19 variants, individuals are encouraged to remain informed and proactive in protecting themselves and their communities.
In summary, Pfizer's updated COVID-19 vaccine has been approved in Canada to target a new variant. Available this fall, it’s recommended for high-risk groups and all eligible adults and children. Monitoring COVID-19 activity through wastewater testing continues to be crucial for public health.
